Search Results

There are 2648 results for: content related to: Introduction to the genetics and biology of interleukin-28B

  1. You have free access to this content
    Role of IL28B for chronic hepatitis C treatment toward personalized medicine

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 2, February 2014, Pages: 241–249, Kentaro Matsuura, Tsunamasa Watanabe and Yasuhito Tanaka

    Article first published online : 27 JAN 2014, DOI: 10.1111/jgh.12475

  2. You have free access to this content
    Host genomics and HCV treatment response

    Journal of Gastroenterology and Hepatology

    Volume 27, Issue 2, February 2012, Pages: 212–222, Paul J Clark and Alexander J Thompson

    Article first published online : 20 JAN 2012, DOI: 10.1111/j.1440-1746.2011.06918.x

  3. You have free access to this content
    Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral response

    Hepatology

    Volume 55, Issue 1, January 2012, Pages: 20–29, Yasuhiro Asahina, Kaoru Tsuchiya, Masaru Muraoka, Keisuke Tanaka, Yuichiro Suzuki, Nobuharu Tamaki, Yoshihide Hoshioka, Yutaka Yasui, Tomoji Katoh, Takanori Hosokawa, Ken Ueda, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Masayuki Kurosaki, Nobuyuki Enomoto, Sayuri Nitta, Naoya Sakamoto and Namiki Izumi

    Article first published online : 29 NOV 2011, DOI: 10.1002/hep.24623

  4. You have free access to this content
    Limited use of interleukin 28B in the setting of response-guided treatment with detailed on-treatment virological monitoring

    Hepatology

    Volume 54, Issue 3, 2 September 2011, Pages: 772–780, Alessandra Mangia, Alexander J. Thompson, Rosanna Santoro, Valeria Piazzolla, Massimiliano Copetti, Nicola Minerva, Daniela Petruzzellis, Leonardo Mottola, Donato Bacca and John G. McHutchison

    Article first published online : 21 JUL 2011, DOI: 10.1002/hep.24458

  5. You have free access to this content
    Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: Impaired viral kinetics and therapeutic response

    Hepatology

    Volume 56, Issue 2, August 2012, Pages: 444–454, Susanna Naggie, Anu Osinusi, Antonios Katsounas, Richard Lempicki, Eva Herrmann, Alexander J. Thompson, Paul J. Clark, Keyur Patel, Andrew J. Muir, John G. McHutchison, Joerg F. Schlaak, Martin Trippler, Bhavana Shivakumar, Henry Masur, Michael A. Polis and Shyam Kottilil

    Article first published online : 2 JUL 2012, DOI: 10.1002/hep.25647

  6. Impaired induction of interleukin 28B and expression of interferon λ 4 associated with nonresponse to interferon-based therapy in chronic hepatitis C

    Journal of Gastroenterology and Hepatology

    Volume 30, Issue 6, June 2015, Pages: 1075–1084, Miyako Murakawa, Yasuhiro Asahina, Mina Nakagawa, Naoya Sakamoto, Sayuri Nitta, Akiko Kusano-Kitazume, Takako Watanabe, Fukiko Kawai-Kitahata, Satoshi Otani, Miki Taniguchi, Fumio Goto, Yuki Nishimura-Sakurai, Yasuhiro Itsui, Seishin Azuma, Sei Kakinuma and Mamoru Watanabe

    Article first published online : 27 APR 2015, DOI: 10.1111/jgh.12902

  7. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Article first published online : 1 OCT 2012, DOI: 10.1002/hep.26040

  8. You have free access to this content
    Hepatitis C pharmacogenetics: State of the art in 2010

    Hepatology

    Volume 53, Issue 1, January 2011, Pages: 336–345, Nezam H. Afdhal, John G. McHutchison, Stefan Zeuzem, Alessandra Mangia, Jean-Michel Pawlotsky, Jeffrey S. Murray, Kevin V. Shianna, Yasuhito Tanaka, David L. Thomas, David R. Booth, David B. Goldstein and for the Pharmacogenetics and Hepatitis C Meeting Participants

    Article first published online : 12 JAN 2011, DOI: 10.1002/hep.24052

  9. Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response

    Journal of Viral Hepatitis

    Volume 19, Issue 5, May 2012, Pages: 332–340, P. J. Clark, A. J. Thompson, M. Zhu, D. M. Vock, Q. Zhu, D. Ge, K. Patel, S. A. Harrison, T. J. Urban, S. Naggie, J. Fellay, H. L. Tillmann, K. Shianna, S. Noviello, L. D. Pedicone, R. Esteban, P. Kwo, M. S. Sulkowski, N. Afdhal, J. K. Albrecht, D. B. Goldstein, J. G. McHutchison, A. J. Muir and for the IDEAL investigators

    Article first published online : 22 FEB 2012, DOI: 10.1111/j.1365-2893.2011.01553.x

  10. Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 1, January 2014, Pages: 102–109, Ming-Yao Chen, Chen-Hua Liu, Ting-Chih Chen, Tung-Hung Su, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao and Chun-Jen Liu

    Article first published online : 19 DEC 2013, DOI: 10.1111/jgh.12329

  11. Lead-in treatment with interferon-β/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha-2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotype

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue 3, March 2013, Pages: 443–449, Norio Itokawa, Masanori Atsukawa, Akihito Tsubota, Chisa Kondo, Satomi Hashimoto, Takeshi Fukuda, Yoko Matsushita, Hideko Kidokoro, Tamaki Kobayashi, Yoshiyuki Narahara, Katsuhisa Nakatsuka, Hidenori Kanazawa, Katsuhiko Iwakiri and Choitsu Sakamoto

    Article first published online : 26 FEB 2013, DOI: 10.1111/jgh.12039

  12. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Article first published online : 15 OCT 2013, DOI: 10.1002/hep.26880

  13. Interleukin 28B polymorphism predicts interferon plus ribavirin treatment outcome in patients with hepatitis C virus-related liver cirrhosis: A multicenter retrospective study in Japan

    Hepatology Research

    Volume 44, Issue 9, September 2014, Pages: 983–992, Satoshi Shakado, Shotaro Sakisaka, Takeshi Okanoue, Kazuaki Chayama, Namiki Izumi, Joji Toyoda, Eiji Tanaka, Akio Ido, Tetsuo Takehara, Kentaro Yoshioka, Yoichi Hiasa, Hideyuki Nomura, Masataka Seike, Yoshiyuki Ueno and Hiromitsu Kumada

    Article first published online : 9 JAN 2014, DOI: 10.1111/hepr.12280

  14. You have free access to this content
    IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C

    Hepatology

    Volume 52, Issue 6, December 2010, Pages: 1888–1896, Thomas J. Urban, Alexander J. Thompson, Shelton S. Bradrick, Jacques Fellay, Detlef Schuppan, Kenneth D. Cronin, Linda Hong, Alexander McKenzie, Keyur Patel, Kevin V. Shianna, John G. McHutchison, David B. Goldstein and Nezam Afdhal

    Article first published online : 7 OCT 2010, DOI: 10.1002/hep.23912

  15. You have free access to this content
    The recent breakthroughs in the understanding of host genomics in hepatitis C

    European Journal of Clinical Investigation

    Volume 40, Issue 10, October 2010, Pages: 950–959, Andri Rauch, Janine Rohrbach and Pierre-Yves Bochud

    Article first published online : 19 AUG 2010, DOI: 10.1111/j.1365-2362.2010.02337.x

  16. The Role of Pharmacogenetics in the Treatment of Chronic Hepatitis C Infection

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 34, Issue 2, February 2014, Pages: 185–201, Marina Kawaguchi-Suzuki and Reginald F. Frye

    Article first published online : 30 SEP 2013, DOI: 10.1002/phar.1349

  17. You have free access to this content
    Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection

    Hepatology

    Volume 53, Issue 1, January 2011, Pages: 317–324, Michael R. Charlton, Alexander Thompson, Bart J. Veldt, Kym Watt, Hans Tillmann, John J. Poterucha, Julie K. Heimbach, David Goldstein and John McHutchison

    Article first published online : 12 JAN 2011, DOI: 10.1002/hep.24074

  18. Interleukin-28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantation

    Journal of Gastroenterology and Hepatology

    Volume 27, Issue 9, September 2012, Pages: 1467–1472, Tomokazu Kawaoka, Shoichi Takahashi, Shintaro Takaki, Akira Hiramatsu, Koji Waki, Nobuhiko Hiraga, Daiki Miki, Masataka Tsuge, Michio Imamura, Yoshiiku Kawakami, Hiroshi Aikata, Hidenori Ochi, Takashi Onoe, Hirotaka Tashiro, Hideki Ohdan and Kazuaki Chayama

    Article first published online : 21 AUG 2012, DOI: 10.1111/j.1440-1746.2012.07129.x

  19. You have free access to this content
    Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection

    Hepatology

    Volume 54, Issue 4, October 2011, Pages: 1127–1134, Francesco Marabita, Alessio Aghemo, Stella De Nicola, Maria G. Rumi, Cristina Cheroni, Rossana Scavelli, Marco Crimi, Roberta Soffredini, Sergio Abrignani, Raffaele De Francesco and Massimo Colombo

    Article first published online : 19 AUG 2011, DOI: 10.1002/hep.24503

  20. Association between IL28B polymorphism, TNFα and biomarkers of insulin resistance in chronic hepatitis C-related insulin resistance

    Journal of Viral Hepatitis

    M. Lemoine, S. Chevaliez, J. P. Bastard, L. Fartoux, O. Chazouillères, J. Capeau, J. M. Pawlotsky and L. Serfaty

    Article first published online : 26 MAR 2015, DOI: 10.1111/jvh.12408